OneMedNet Corp Warrant (ONMDW)
Stock · NASDAQ · Health Care
$0.0328as of 10/6/2026
Price chart
Active signals
No technical signal is currently active for this symbol.
Support level
$0.027519
Industry
Biotechnology: Commercial Physical & Biological Resarch
About ONMDW
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets. The company also provides BEAM, a medical imagin…
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Employees
- 22
Fundamentals
- 1-day range
- Market cap
- $2.37M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 3.85
- Avg. volume
- —
52-week range
$0.0175$0.242
OneMedNet Corp Warrant Competitors
Chosen by industry and closest market cap.
- ONMDWOneMedNet Corp Warrant$0.0328▲ 13.10%Market cap $2.37MP/E —$0.0175$0.242
- ISPCiSpecimen Inc. Common Stock$0.917▼ 10.97%Market cap $3.35MP/E —$1.02$36.32
- BIAFbioAffinity Technologies Inc. Common Stock$3.73▼ 5.81%Market cap $4.12MP/E —$4.56$80.7
- ONMDOneMedNet Corp Class A Common Stock$4.51▼ 5.05%Market cap $37.18MP/E —$4.9$42.2
- MXCTMaxCyte Inc. Common Stock$1.3▲ 0.00%Market cap $118.91MP/E —$0.643$1.87
- OABIOmniAb Inc. Common Stock$4.59▼ 2.96%Market cap $324.74MP/E —$1.3$5.43
- NRCNRC Health Common Stock$20.15▼ 4.55%Market cap $430.67MP/E 79.70$11.01$23.68
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ONMDW OneMedNet Corp Warrant | $2.37M | — | $0.0328 | ▲ 13.10% | $0.0175$0.242 |
| ISPC iSpecimen Inc. Common Stock | $3.35M | — | $0.917 | ▼ 10.97% | $1.02$36.32 |
| BIAF bioAffinity Technologies Inc. Common Stock | $4.12M | — | $3.73 | ▼ 5.81% | $4.56$80.7 |
| ONMD OneMedNet Corp Class A Common Stock | $37.18M | — | $4.51 | ▼ 5.05% | $4.9$42.2 |
| MXCT MaxCyte Inc. Common Stock | $118.91M | — | $1.3 | ▲ 0.00% | $0.643$1.87 |
| OABI OmniAb Inc. Common Stock | $324.74M | — | $4.59 | ▼ 2.96% | $1.3$5.43 |
| NRC NRC Health Common Stock | $430.67M | 79.70 | $20.15 | ▼ 4.55% | $11.01$23.68 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific RegionYahoo · 10/7/2026
- OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data SolutionYahoo · 9/30/2026
- OneMedNet Corporation Announces 1-for-10 Reverse Stock SplitYahoo · 9/25/2026
- Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model DevelopmentYahoo · 9/22/2026
- OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos HealthYahoo · 9/22/2026
- OneMedNet Reports Record Bookings as Faster Fulfillment BeginsYahoo · 9/18/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 5.29M
- Total value held
- $349.4K
- Institutional holders
- 14
Top holders this quarter
- Unknown2.91M
- Unknown871.7K
- Unknown420.0K
- Unknown330.5K
- Unknown256.9K
- Unknown144.4K
- Unknown128.6K
- Unknown83.7K
- Unknown49.7K
- Unknown30.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
OneMedNet Signs Seven-Figure Data Agreement
OneMedNet announced a multiyear, seven-figure agreement to power a partner's derivative data solution. This contract highlights the company's ability to secure significant revenue from data partnerships. The news provides context for the stock's current position near its 52-week low.
OneMedNet Signs Seven-Figure Data Agreement. OneMedNet announced a multiyear, seven-figure agreement to power a partner's derivative data solution. This contract highlights the company's ability to secure significant revenue from data partnerships. The news provides context for the stock's current position near its 52-week low.